Epclusa with Antacids
Epclusa (sofosbuvir/velpatasvir) can be taken with antacids, but you must separate the administration by 4 hours to avoid reduced velpatasvir absorption and potential treatment failure. 1
Key Administration Guidelines
Antacids (aluminum/magnesium hydroxide)
- Separate by 4 hours from Epclusa administration 1
- This is a firm requirement, not a suggestion
- Velpatasvir solubility decreases as gastric pH increases, leading to reduced drug concentrations
H2-Receptor Antagonists (e.g., famotidine)
- May be given simultaneously with Epclusa OR separated by 12 hours 1
- Maximum dose: equivalent to famotidine 40 mg twice daily
- More flexible timing than antacids
Proton-Pump Inhibitors (e.g., omeprazole)
- Coadministration is NOT recommended 1
- If medically necessary:
- Take Epclusa with food
- Give Epclusa 4 hours before omeprazole 20 mg
- Limited to omeprazole 20 mg only; other PPIs not studied
- A recent case report suggests co-administration with soda may overcome this interaction 2, but this is not yet standard practice
Clinical Rationale
The interaction occurs because velpatasvir is a pH-dependent drug—its absorption decreases significantly in higher pH environments. Acid-reducing agents raise gastric pH, potentially leading to:
- Subtherapeutic velpatasvir levels
- Treatment failure
- Development of resistance-associated substitutions
The FDA label explicitly addresses this based on pharmacokinetic studies showing decreased velpatasvir concentrations with acid-reducing agents 1.
Common Pitfalls to Avoid
- Don't assume all acid reducers are the same: Antacids require 4-hour separation, H2-blockers are more flexible, and PPIs should generally be avoided
- Don't forget food with PPIs: If you must use a PPI, Epclusa must be taken with food for this specific scenario
- Don't exceed recommended PPI doses: Only omeprazole 20 mg has been studied; higher doses or other PPIs lack safety data